EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Phage-induced protection against lethal bacterial reinfection

Yikun Xing iD, Haroldo J Hernandez Santos iD, Ling Qiu iD, Samantha R Ritter iD, Jacob J Zulk iD, Rachel Lahowetz iD, Kathryn A Patras iD, Austen L Terwilliger iD, Anthony W Maresso iD

Proceedings of the National Academy of Sciences · 2025

DOI: 10.1073/pnas.2423286122 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2025. Verfasst von Yikun Xing und 8 weiteren Autor:innen. Beteiligte Einrichtung: TAILOR Labs, Baylor College of Medicine, Houston, TX 77030. Hauptthemen laut MEDLINE: Phage Therapy, Bacteriophages, Reinfection, Bacterial Infections. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID), NIAID NIH HHS, Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation (Kleberg Foundation).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bacteriophages, or phages, are viruses that target and infect bacteria. Due to a worldwide rise in antimicrobial resistance (AMR), phages have been proposed as a promising alternative to antibiotics for the treatment of resistant bacterial infections. Up to this point in history, phage use in preclinical animal studies, clinical trials, and emergency-use compassionate care cases has centered around the original observation from 1915 showing phage as lytic agent, and thus a treatment that kills bacteria. Here, we describe an activity associated with phage therapy that extends beyond lytic activity that results in long-term protection against reinfection. This activity is potent, providing almost complete protection against a second lethal infection for animals treated with phage therapy. The activity also reduced infection burden an astounding billion-fold over the control. Reinfection protection requires phage lytic killing of its target bacterium but is independent of additional phage therapy. The effect is not driven by phage alone, lingering phage resistors, or a sublethal inoculum. In vitro phage-lysed bacteria provide partial protection, suggesting a combination of phage-induced lytic activity and immune stimulation by phage treatment is responsible for the effect. These observations imply certain phages may induce host adaptive responses following the lysis of the infecting bacteria. This work suggests phage therapy may contain a dual-action effect, an initial treatment efficacy followed by a long-term protection against reoccurring infection, a therapeutic-vaccination mechanism of action.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Phage TherapyBacteriophagesReinfectionBacterial InfectionsAnimalsMice

Stichwörter der Autor:innen

ExPECimmunityphage therapysepsis

Autor:innen und Institutionen

  • TAILOR Labs, Baylor College of Medicine, Houston, TX 77030.
  • Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030.
  • Alkek Center for Metagenomics and Microbiome Research, Baylor College of Medicine, Houston, TX 77030.

ORCID-Profile: Yikun Xing, Haroldo J Hernandez Santos, Ling Qiu, Samantha R Ritter, Jacob J Zulk, Rachel Lahowetz, Kathryn A Patras, Austen L Terwilliger, Anthony W Maresso

Förderung

  • HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
  • NIAID NIH HHS
  • Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation (Kleberg Foundation)
  • HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
  • NIDDK NIH HHS

Zitieren

APA

Xing, Y., Hernandez Santos, H. J., Qiu, L., Ritter, S. R., Zulk, J. J., Lahowetz, R., Patras, K. A., Terwilliger, A. L., & Maresso, A. W. (2025). Phage-induced protection against lethal bacterial reinfection. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2423286122

Vancouver

Xing Y, Hernandez Santos HJ, Qiu L, Ritter SR, Zulk JJ, Lahowetz R, et al. Phage-induced protection against lethal bacterial reinfection. Proceedings of the National Academy of Sciences. 2025. doi:10.1073/pnas.2423286122

BibTeX
@article{Xing2025,
  author = {Xing, Yikun and Hernandez Santos, Haroldo J and Qiu, Ling and Ritter, Samantha R and Zulk, Jacob J and Lahowetz, Rachel and Patras, Kathryn A and Terwilliger, Austen L and Maresso, Anthony W},
  title = {Phage-induced protection against lethal bacterial reinfection},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2025},
  doi = {10.1073/pnas.2423286122}
}
Kostenlos starten →